In the News

Between 2,150 and 4,100 children suffered from severe malformations connected to valproate prescription.

Reduced usage of antipsychotics in first-episode psychosis was associated with improved executive functioning.

Previously taking antidepressants could make individuals less likely to respond to treatment for bipolar II depression.

Researchers found that veterans with both conditions had higher odds of being prescribed second-generation antipsychotics than those presenting with just PTSD.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

The “Mediterranean diet” has been associated with reduced risk of depressive symptoms, and a new study demonstrates that dietary changes may be an effective treatment intervention.

Criticisms of the DSM-5 spark alternative proposals and calls to reform diagnostic systems in the mental health field.

Study finds more patients are visiting physicians who have ties to industry than previously thought.

“This research points to the inadequacy of asking the simple question: ‘Do antidepressants work?’ Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in people’s lives.”

Researchers experimenting on mice found that Lactobacillus—the probiotic commonly found in yogurt—may help reduce depressive symptoms in reaction to chronic stressors. But human studies have found mixed results.

The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.

A new study suggests that depressive symptoms in older adults can be improved with non-invasive behavioral activation techniques. These approaches appear to have a preventative effect, serving to prevent further depressive symptoms from developing.

Findings show that despite increases in treatment availability, the prevalence of mental health issues has not decreased.

Behind the U.S. task force recommendation to screen all children and adults for depression.

Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed

A study published in Frontiers in Human Neuroscience proposes a new model for the treatment of adolescents diagnosed with major depressive disorder (MDD).

Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD

Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.

Study finds antidepressant use is linked to increase in hip fractures in community-dwelling older adults with and without Alzheimer’s disease.

BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics

Researchers recommend that healthcare professionals be vigilant regarding the signs of respiratory failure among patients with COPD who are receiving antipsychotics, especially during the initial treatment phase.

New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms

The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.

Researchers believe that side-effect monitoring is critical because of the increase in the use of antipsychotics

Researchers find that patients are prescribed more pills than necessary after common surgical procedures